Intelligence

UK on global map
#BioIndustry Association #Biologics / Biotechnology #Equity finance #Finance #Fundraising #Investment #Life sciences #Market reporting #Private investment #Seed funding #UK

UK remains strongest biotech hub in Europe despite general decline

After a disappointing start to the year, the last few months have seen a boost to fundraising for UK biotech companies. DDW’s Diana Spencer unpacks the Q3 figures and annual predictions from the BioIndustry Association1.  While 2021 was the highest year on record for… Read More

#Business & Investment #Exclusive Content #Market Reports

#Antibodies #Antibody binding #Flow Cytometry #T cell activation #Whitepaper

High throughput, multi-parametric analysis accelerates antibody discovery workflows

In this whitepaper, we present the unique benefits of the high-throughput iQue®Advanced Flow Cytometry Platform, combined with built-in, visual-based iQue Forecyt®software, in the antibody discovery workflow. Learn analysis details of: Antibody Binding Antibody Internalisation and Viability ADCP Measurement in Adherent Cells ADCP Measurement in Suspension Cells Quantification of NK Cell-Mediated… Read More

#Intelligence #Resources

#Biotechnology #Drug discovery #Life sciences #Pharmacology

What’s interesting about Australian drug discovery? 

Australia’s drug discovery industry shows promise and innovation, as well as business opportunities. DDW’s Megan Thomas takes a look at some of the reasons why we should be keeping an interested eye on the developments coming out of this country.   The Sector Snapshot 2022: Expansion is continuous … Read More

#Exclusive Content #Market Reports #Trends & Analysis

Japanese flag
#Biopharmaceutical #Collaboration #Drug discovery #Healthcare #Investment #Life sciences #Market reporting #Start-ups

A review of Japan’s drug discovery landscape  

DDW Multimedia Editor Megan Thomas takes a broad look at the drug discovery and development landscape in Japan and highlights how it is bolstered by government policies, investment, collaboration, start-up ecosystems and academic research.   Japan continues to be one of the largest pharmaceutical markets in the world,… Read More

#Business & Investment #Editor's Choice #Exclusive Content #Market Reports #Trends & Analysis

#Electroporation #Gene delivery #Whitepaper

Electroporation Made Easy for Hard-to-Transfect Cells

Download the latest Mirus Bio whitepaper to learn about: The differences between gene delivery methods (electroporation, chemical transfection and viral transduction). Optimising electroporation with the Ingenio(R) EZporator(R) Electroporation System. Electroporate multiple cell types with high efficiency and viability. Deliver different molecular cargo. Read More

#Intelligence #Resources

Basel map
#Biologics / Biotechnology #Cancer immunotherapy #Immuno-oncology #Market reporting #Oncology #Start-ups

Basel: a centre for ground-breaking oncology 

Listen to this article on the DDW podcast: Dr Stephan Emmerth and Paul Eschmann, Basel Area Business & Innovation, explain the benefits of being based in Basel – the talent pool, global players, academic institutions and investors, for example.  Companies specialising in oncology R&D… Read More

#Exclusive Content #Market Reports

App Note: Rapid Development of Automated Sars-CoV-2 Clinical Diagnostics
#App note #Automated liquid handling #Automation / robotics #Clinical diagnostics #Covid-19 #Liquid handling #SARS-CoV-2

Rapid development of automated Sars-CoV-2 clinical diagnostics

Download the App Note to learn about: How to create and share an automated workflow for rapid development and validation of SARS-CoV-2 clinical diagnostics. The highly scalable liquid handling platform, CyBio FeliX for clinical diagnostics – it provides magnetic bead-based nucleic acid extraction, eliminating laborious and time-consuming column-based binding and… Read More

#App Notes #Intelligence #Resources

eBook cover
#Antibody-based therapeutics #Drug development #Monoclonal antibodies

Efficiently develop antibody-based therapeutics

In the Quality by Design (QbD) approach to antibody-based therapeutics development, stability characterisation —the probability of a protein unfolding or denaturing— is performed to ensure that structure and function are preserved throughout development and manufacturing.  Antibodies are affected by many factors along their journey to become therapeutics. Read More

#Resources

#Biopharma #Digitalisation #Regulatory

The next steps for biopharma regulations

Following a decade of solid groundwork to modernise regulatory information management in life sciences, leading companies have now shifted their focus to how they might exploit this new digital landscape – to transform process management; improve data exchange with the enterprise at large; revisit organisational structures… Read More

#Exclusive Content #Regulatory #Trends & Analysis

#Drug development #Microfluidics #Organ-on-a-chip #Tissue chips

Using microfluidics in drug discovery

Download this 24-page DDW eBook, sponsored by Emulate, to learn about: How microfluidics is fuelling innovation in drug discovery A detailed look at the organ-on-a-chip sector How human tissue chips are helping advance our understanding of biology Download now. Read More

#DDW eBooks #Intelligence

#Afucosylated mAb expression #Antibody #Antibody-dependent cellular cytotoxicity #Glycoengineered antibodies

Afucosylated mAb expression benefits therapeutic antibody efficacy

Currently, at least 35 glycoengineered antibodies, with their Fc fucose partially or entirely removed, have been investigated in animal models or clinical trials. The absence of fucose on the Fc N-glycan increases IgG1 Fc binding affinity to the FcγRIIIa on immune effector cells like natural killer cells. It results in… Read More

#App Notes #Intelligence #Resources

#Immunology #In vivo #Mouse models #T-Cells

Read the Top Five Benefits of a Cloud ELN

As experimental data becomes bigger and more complex, scientists are challenged to make discoveries faster, consistently document and analyse their work, and easily collaborate across an organisation and with external partners. Electronic lab notebooks (ELN) provide access to all collaborators 24/7, wherever they are and whether they are employees or… Read More

#Intelligence #Resources

#Clinical development #Immunology / Virology & Vaccines #Infectious diseases #mRNA #Public health

mRNA technology may hold the future for a cytomegalovirus vaccine 

Listen to this article on the DDW podcast: Allison August, M.D., Vice President, Clinical Development, Infectious Diseases at Moderna examines the data on cytomegalovirus (CMV), why attempts at vaccines for CMV have so far proved elusive and the emerging options to address this unmet need. … Read More

#Exclusive Content #Trends & Analysis

#Biopharmaceuticals #Drug development #Liquid handling #Research

LC-MS Analysis for (Bio)pharmaceutical Research

In the seventh eBook of the Hamilton series “LC-MS Analysis for (Bio)pharmaceutical Research”, we discuss: The role of LC-MS in the drug development process The drivers behind the need for LC-MS sample prep automation in biopharma The modules and full liquid handling automation solutions that Hamilton offers for LC-MS… Read More

#Intelligence #Resources